AOD9604 vs Tesamorelin
| Attribute | AOD9604 Anti-Obesity Drug 9604 | Tesamorelin Stabilized GHRH analog |
|---|---|---|
| Category | Weight Loss & Metabolism | Muscle Growth & Performance |
| Best known for | Lipolysis without GH side-effects | Visceral fat reduction research |
| In plain English | AOD9604 isolates the fat-burning effect of growth hormone without the muscle-building or blood-sugar effects. | Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically. |
| How it works | Stimulates lipolysis and inhibits lipogenesis without significant effect on IGF-1, insulin sensitivity, or glucose. | Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue. |
| Researchers study | Obesity, body composition, and osteoarthritis (intra-articular use). | Visceral fat reduction, lipid metabolism, and cognitive function in older adults. |
| Internet discussion | Discussed for targeted fat loss. | Discussed by people specifically targeting belly fat. |
AOD9604
Lipolysis without GH side-effects
AOD9604 isolates the fat-burning effect of growth hormone without the muscle-building or blood-sugar effects.
Stimulates lipolysis and inhibits lipogenesis without significant effect on IGF-1, insulin sensitivity, or glucose.
Obesity, body composition, and osteoarthritis (intra-articular use).
Discussed for targeted fat loss.
AOD9604 is an hGH fragment researched for fat-burning effects without anabolic side effects.
Tesamorelin
Visceral fat reduction research
Tesamorelin is the GH peptide with the strongest data for shrinking visceral (belly) fat specifically.
Activates GHRH receptors, increasing GH and IGF-1 with documented preferential effects on visceral adipose tissue.
Visceral fat reduction, lipid metabolism, and cognitive function in older adults.
Discussed by people specifically targeting belly fat.
Tesamorelin is the GHRH analog with strongest data for reducing visceral fat specifically.